Harbour Investments »

Gain Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $22k 11k 2.03

More positions owned by Harbour Investments

Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
Apple Stock (AAPL)
Avantis Emerging Markets Equity Etf Etf (AVEM)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ft Vest Laddered Buffer Etf Etf (BUFR)
State Street Spdr S&p 500 Etf Etf (SPY)
Capital Group Core Plus Income Etf Etf (CGCP)
First Trust Rising Dividend Achievers Etf Etf (RDVY)
Ishares S&p 500 Growth Etf Etf (IVW)
State Street Spdr Portfolio S&p 500 Etf Etf (SPYM)
Vanguard Morningstar Growth Etf Etf (VUG)

View all positions for Harbour Investments

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
GSA Capital Partners
Jones Financial Companies, L.L
Cambridge Investment Research Advisors
DME Capital Management
Vanguard Capital Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
UBS Group
Stratos Wealth Partners
Citadel Advisors
Cresset Asset Management
State Street Corporation

View all funds holding Gain Therapeutics